Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Article Title Journal
Immune Checkpoint Inhibition in Marjolin Ulcer: A Case Series Journal of Immunotherapy
Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysis BMC Cancer
Learning Conditional Variational Autoencoders with Missing Covariates arXiv
Generalizable EHR-R-REDCap pipeline for a national multi-institutional rare tumor patient registry Jamia Open
Regionally Metastatic Merkel Cell Carcinoma Associated with Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis Case Reports in Oncological Medicine
Real-world assessment of response to anti-PD-1 therapy in advanced cutaneous squamous cell carcinoma Journal of the American Academy of Dermatology
Survival prognosis and variable selection: A case study for metastatic castrate resistant prostate cancer patients F1000 Research
The Use of External Control Data for Predictions and Futility Interim Analyses in Clinical Trials Neuro-Oncology
Enhancing the analytic utility of clinical trial data to inform health disparities research Contemporary Clinical Trials Communications
Translation of Prognostic and Pharmacodynamic Biomarkers from Trial to Non-trial Patients with Metastatic Castration-resistant Prostate Cancer Treated with Docetaxel Clinical Oncology
Semi-automated Conversion of Clinical Trial Legacy Data into CDISC SDTM Standards Format Using Supervised Machine Learning Methods of Information in Medicine
Community mining of open clinical trial data Oncotarget
Reflections on Sharing Clinical Trial Data: Challenges and a Way Forward: Proceedings of a Workshop (2020) National Academies Press
Follow‑Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under‑Reporting in Oncology Trials? Drug Safety

Pages